Find a Doctor
Cancer Focus: Adrenal Carcinoma, Anal Cancer, Appendiceal (Appendix) Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer, Ductal Carcinoma In Situ, Esophageal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumor, GIST (Gastrointestinal Stromal Tumor), Glioblastoma, Head and Neck Cancer, Hodgkin Lymphoma, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Kidney (Renal Cell) Cancer, Leukemia, Liver Cancer, Lung Cancer, MDS, Melanoma, Merkel Cell Carcinoma, Mesothelioma, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Neuroendocrine Tumor, Non-Hodgkin Lymphoma, Oral Cavity or Throat Cancer, Osteosarcoma, Pancoast Tumor, Pancreatic Cancer, Penile Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Skin Cancer (Nonmelanoma), Small Intestine Cancer, Squamous Cell Carcinoma, Stomach (Gastric) Cancer, Testicular Cancer, Throat Cancer, Thymoma, Thyroid Cancer, Tongue Cancer, Triple Negative Breast Cancer
Dr. Laber is a hematologist/oncologist and senior member with Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital. Dr. Laber earned his M.D. at the University of Buenos Aires, Argentina. He completed his residency in internal medicine at Cleveland Clinic Health System, and was designated Chief Resident during his term at Hillcrest and Southpointe Hospitals. Dr. Laber’s research interests have been devoted to translational research with special interest in hematology, genitourinary malignancies, gastrointestinal malignancies, and early clinical trials of new therapies. He has been the principal investigator in multiple clinical trials that have led to the development and approval of novel therapies for several cancers including prostate, kidney, colon, breast, lung, myeloproliferative disorders and many other malignancies. Dr. Laber’s other areas of research interest include heparin-induced thrombocytopenia, thrombosis in cancer, venous thromboembolism, coagulation and bleeding disorders. Dr. Laber has published in prestigious scientific journals such as The New England Journal of Medicine, Journal of Clinical Oncology, Blood, Cancer Investigation, American Journal of Hematology and European Journal of Haematology.
Education & Training
65 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including: